Anna Tsimelzon, Ph.D.

Affiliations: 
University of California, Santa Cruz, Santa Cruz, CA, United States 
Area:
asymmetric and/or enantioselective methods, development of an optical glucose sensor
Google:
"Anna Tsimelzon"
Mean distance: 9.33
 
SNBCP

Parents

Sign in to add mentor
Rebecca Braslau grad student 2005 UC Santa Cruz
Bakthan Singaram grad student 2005 UC Santa Cruz
 (Radical [n+1] annulations with sulfur dioxide and new methodology for the synthesis of specialized N-alkoxyamines.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gu G, Tian L, Herzog SK, et al. (2020) Hormonal modulation of ESR1 mutant metastasis. Oncogene
De Angelis C, Nagi C, Hoyt CC, et al. (2019) Evaluation of the predictive role of tumor immune infiltrate in HER2-positive breast cancer patients treated with neoadjuvant anti-HER2 therapy without chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Sethunath V, Hu H, De Angelis C, et al. (2019) . Molecular Cancer Research : McR
Fu X, Pereira R, Zhao D, et al. (2017) Abstract PD2-04: FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer Cancer Research. 77
Gu G, Tian L, Gao M, et al. (2017) Abstract 22: The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis Cancer Research. 78: 22-22
Mazumdar A, Hill J, Zhang Y, et al. (2017) Abstract 5525: Induced expression of PPM1A in ER-negative breast cancer cells inhibits growth by suppressing CDK phosphorylation Cancer Research. 77: 5525-5525
Fu X, Jeselsohn R, Pereira R, et al. (2016) FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 113: E6600-E6609
Ochsner SA, Tsimelzon A, Dong J, et al. (2016) Research Resource: A reference transcriptome for constitutive androstane receptor and pregnane X receptor xenobiotic signaling. Molecular Endocrinology (Baltimore, Md.). me20161095
Mazumdar A, Poage GM, Shepherd J, et al. (2016) Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast Cancer Research and Treatment
Gelsomino L, Gu G, Rechoum Y, et al. (2016) ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling. Breast Cancer Research and Treatment
See more...